Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6091815 | Gastroenterology | 2016 | 22 Pages |
Abstract
Eight weeks of treatment with the combination of sofosbuvir, velpatasvir, and GS-9857 produced an SVR12 in most treatment-naïve or previously treated patients with HCV genotype 1 or 3 infections, including those with compensated cirrhosis. ClinicalTrials.gov, Number: NCT02202980.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Edward J. Gane, Christian Schwabe, Robert H. Hyland, Yin Yang, Evguenia Svarovskaia, Luisa M. Stamm, Diana M. Brainard, John G. McHutchison, Catherine A. Stedman,